DEF: Splash Beverage Seeks Massive Share Increase

Splash Beverage Group, Inc. will hold a special meeting on August 29, 2025, to vote on increasing its authorized common stock from 7.5 million to 400 million shares, a move the company states is crucial for future financing and operational flexibility.

Summary

• Splash Beverage Group, Inc. is holding a Special Meeting of Stockholders on August 29, 2025, to vote on a proposal to amend its Articles of Incorporation.
• The proposed amendment seeks to increase the number of authorized shares of common stock from 7,500,000 to 400,000,000.
• The Board of Directors unanimously recommends voting FOR this proposal.
• As of the Record Date (August 6, 2025), 2,143,480 common shares and 1,000 Series A Preferred Shares were outstanding.
• The company currently has only 83,483 unissued and unreserved authorized common shares available for future issuance, after accounting for shares reserved for warrants (2,154,325) and equity awards (3,118,712).
• Series A Preferred Shares carry super-voting rights (25,000 votes per share) on this specific proposal, mirroring the voting proportion of common shareholders to amplify their preference. These preferred shares will be redeemed upon approval of the proposal.

Sentiment

Score: 3

Explanation: The filing reveals critical financial distress, including non-compliance with NYSE American listing standards and recent late SEC filings, which are significant red flags. While the proposed share increase aims to provide financial flexibility, its sheer magnitude suggests a high probability of substantial future dilution, which is generally negative for existing shareholders. The company's appeal against delisting adds to the uncertainty.

Positives

• Increased authorized shares provide flexibility for future equity financings to fund operations.
• Allows for future awards under stockholder-approved equity incentive plans, aiding in attracting and retaining qualified management.
• Enables the company to act quickly on corporate opportunities without the delay and expense of convening special meetings for capital increases.
• Provides flexibility for potential future acquisitions, strategic relationships, and other general corporate purposes.
• The Board believes the increase will provide greater risk-adjusted returns over the long term.

Negatives

• Future issuance of additional shares could dilute the earnings per share, book value per share, and voting rights of existing stockholders.
• The significant increase in authorized shares (from 7.5 million to 400 million) suggests a high potential for substantial future dilution.
• The company is currently not in compliance with NYSE American listing standards, facing potential delisting.
• Recent late filings of Annual and Quarterly Reports (10-K and 10-Q) may negatively affect investor confidence and expose the company to regulatory scrutiny.

Risks

• Late filing of Annual Report on Form 10-K for fiscal year ended December 31, 2024, and Quarterly Report on Form 10-Q for quarter ended March 31, 2025, which were filed on July 11, 2025, and July 22, 2025, respectively, exposing the company to regulatory risks and potentially negatively affecting investor confidence.
• Non-compliance with NYSE American continued listing standards, specifically minimum stockholders equity requirements ($2 million, $4 million, $6 million), leading to deficiency notices between October 2023 and June 2024.
• NYSE Regulation initiated delisting proceedings on April 7, 2025, due to failure to meet required equity levels by April 6, 2025.
• The company appealed the delisting determination on June 26, 2025, with an outcome expected in 60 to 90 days, but there is no assurance of maintaining NYSE American listing.
• Potential delisting from NYSE American could lead to limited market quotations, reduced liquidity, designation as a penny stock, limited news/analyst coverage, and decreased ability to issue additional securities or obtain financing.
• Failure to approve the authorized share increase proposal would limit business development and financing alternatives, potentially severely harming stockholder value.
• Lack of sufficient unissued and unreserved authorized shares could adversely impact the ability to attract, retain, and motivate highly qualified management through equity incentive opportunities.
• Future issuance of additional common or preferred stock could dilute the earnings per share, book value per share, and voting rights of existing stockholders.
• An increase in authorized shares may make it more difficult to obtain control of the company by means of a takeover bid, though the Board states this is not the intent.

Future Outlook

The company anticipates needing to raise cash through future equity financings to fund operations, pursue potential acquisitions, and fulfill existing contractual obligations. It also expects to make future equity awards under incentive plans. The Board believes the authorized share increase will provide greater risk-adjusted returns over the long term and is essential for the company's growth and success, including initiating or completing clinical trials, corporate collaborations, and strategic business development initiatives.

Management Comments

• Our Board unanimously recommends that the stockholders vote FOR the increase in authorized shares proposal being put before our stockholders at the meeting.
• The Board determined that the issuance of the Preferred Shares, with super-voting rights, to be in the best interests of the Company and its shareholders.
• In addition, the Board and management believe that the authorized increase proposal will provide multiple benefits to shareholders, including greater risk-adjusted returns over the long term.
• Because any votes cast by the holder of the Preferred Shares are required to mirror the actual votes cast by holders of the Common Shares, the super-voting rights will serve to amplify the voting preference of the holders of Common Shares who vote on the authorized increase Proposal, and therefore will not override the affirmatively expressed preference of the voting holders of Common Shares.
• We believe the Company will do additional financings in the immediate near future, and will need the ability to raise cash in the future in one or more equity financings to fund our operations, or for potential future acquisitions, as well as to affect future awards under stockholder-approved equity incentive plans or for other general corporate purposes.
• The Board believes this is good governance and standard for many companies at this stage of development.
• The Board of Directors does not intend or view the proposed increase in the number of authorized shares of common stock as an anti-takeover measure and is not aware of any attempt or plan to obtain control of the Company.

Industry Context

The proposed significant increase in authorized shares is a common strategy for companies, particularly those in growth phases or facing financial challenges, to ensure flexibility for future capital raises, strategic transactions, and employee incentives. The company's non-compliance with NYSE American listing standards and recent late filings suggest it is operating under financial and regulatory pressure, making access to capital markets critical for its continued operations and growth within the beverage industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for significant dilution of ownership, earnings per share, and voting power if the authorized shares are issued. Risk of delisting from NYSE American could severely impact liquidity and stock price.
• Employees/Management: Increased authorized shares allow for future equity incentive awards, which can aid in attracting, retaining, and motivating qualified personnel.
• Creditors: The ability to raise capital through equity financings could improve the company's financial stability, potentially benefiting creditors by reducing default risk. The need to fulfill existing contractual obligations related to outstanding notes also impacts creditors.

Next Steps

• Special Meeting of Stockholders to be held on August 29, 2025, to vote on the authorized share increase proposal.
• If approved, the amendment will become effective upon filing a certificate of amendment with the Secretary of State of Nevada.
• The company expects the outcome of its appeal to the NYSE Listings Qualifications Panel regarding delisting to be announced within sixty to ninety days from June 26, 2025.
• The company anticipates additional financings in the immediate near future.
• Final voting results will be reported in a Current Report on Form 8-K within four business days of the Special Meeting.

Key Dates

Recommendation

The filing reveals severe underlying financial distress, including non-compliance with NYSE American listing standards and ongoing delisting proceedings, coupled with a history of late SEC filings. The proposed massive increase in authorized shares, while framed as a flexibility measure, strongly indicates an imminent need for substantial dilutive equity financing to sustain operations. This combination of regulatory risk, financial instability, and high potential for dilution presents a highly unfavorable outlook for current shareholders, warranting a sell recommendation.

Keywords

Splash Beverage Group, SBEV, Authorized Shares, Stock Dilution, SEC Filing, Proxy Statement, Corporate Governance, Capital Raise, NYSE American, Delisting Risk, Shareholder Meeting, Common Stock, Preferred Stock, Equity Financing, Risk Factors